Environmental responsibility, social conscience, and good governance are the guiding principles motivating these strategic partners to help fight the spread of contagious diseases.
Environmental responsibility, social conscience, and good governance are the guiding principles motivating these strategic partners to help fight the spread of contagious diseases.
Since leaving Canada at 17 to pursue a basketball dream, Annabelle Morgan, PhD, publicly known as Dr. Annabelle, now balances life as a mother of 4, scientist, educator, and author. The dynamic life experiences that encompassed her journey has sparked a deep desire to help others. Growing up in Saskatchewan, Canada, Dr. Annabelle was a 4-sport captain graduating with a 4.0 GPA out of high school. She double majored in Biology and Chemistry and played college basketball for Dillard University in New Orleans, winning 2 conference championships, and student-athlete award 2 years in a row. Unfortunately, Dr. Annabelle did not get to play her senior year as Hurricane Katrina had hit at the start of the season.
In the following years, Dr. Annabelle turned down an offer to play basketball overseas and focused on charitable work for NFL organizations while shadowing various physicians looking to further her education and spark her next path.
She started graduate work at Georgetown University in Neuroscience, where her research focused on the partitioning of the thalamus by the Eph-Ephrin Receptors and Ligands. Dr. Annabelle completed her PhD in Cell and Developmental Biology at Vanderbilt University in Nashville, where she now resides. At Vanderbilt, Annabelle focused on genetic mutations that mimic the offset effects that chemotherapy has on heart disease. She has presented and published on the resulting cardiotoxicity as well as on the developing cardiac mesothelium. Dr. Annabelle has also completed the NIH clinical trial certification.
During her training, Dr. Annabelle experienced life-changing personal trauma that shifted her focus towards alternative medicine and natural health consciousness. Through Dr. Annabelle’s guidance, her father overcame terminal cancer 10 years ago and has recently just retired. But perhaps the most significant experience is her son Macario, now 4, who has had over 38 percent of his brain resected as a result of uncontrollable seizures. Dr. Annabelle developed a natural hemp-derived medicine to replace her son’s medications. Bridging the gap with application between her scientific knowledge and discovery of plant compounds, Dr. Annabelle fearlessly treated her son beginning at 7 months old. Since then, he has beaten all odds and has no developmental deficits. Macario is a healthy, normal preschooler. It was at that time that Dr. Annabelle realized her purpose in helping people.
Dr. Annabelle has now left academia in order to pursue the possibilities of implementing cannabis and/or plant compounds in general into current modern medicine. As a result, she has dedicated herself to educating to colleagues worldwide on the connection between the complexity of disease and the significance of utilizing natural components of plants, such as cannabis, to make medicine a more efficient, safe, and personalized process. She consults on medical cannabis legalization, standards, and protocols for a variety of countries and firms. More specifically, Dr. Annabelle has dived into a diversity of research initiatives in hopes to encourage a more embodied approach to precision medicine, where communication between scientists, doctors, and in between are better implemented. A coin she termed, the upstairs downstairs effect. Her dream is to see a more out of the box medicine protocol which personalizes specific treatments for specific conditions, based on an individuals’ genetic and cellular characteristics. In her opinion, the miraculous recovery of her son is no mistake and should be an example of the need to empower medicine today.
Carroll L. Turner is a community minded professional and was a trustee of the Lanier Technical College Foundation for several years before becoming director of and opening the Lanier Technical College Business Incubator in January 2007, which is now the Business Incubator at Brenau University. Carroll was the Executive Director until he retired in May 2019. He is active serving on the Board of Director’s with the Dawson County Chamber of Commerce. Carroll is a past member of the Northeast Georgia Health System Institutional Review Board and past Chairman of the North Georgia Heart Foundation. He is founder of Becon Medical Corporation which developed the biopsy punch and Turner Medical Corporation, a leader in the AED (Automated External Defibrillator) field. He also reinvented Carolina Medical, Inc., bringing it to prominence by manufacturing surgical devices, (ultrasound and blood flow meters) for open heart procedures. He served as CEO of Carolina Medical from March 1999 until March 2005, at which time he founded Becon Medical. While at Carolina Medical, Inc. he served simultaneously as President of Advanced Biosensor, Inc., a start-up (cardiology) company. He was instrumental in commercializing several NASA developed medical monitoring devices. From January 1997 to April 1999 he was Regional Director for the cardiac pacemaker division of ELA* Angeion Corporation. From 1974 through 1996 he served the medical industry in various manufacturing, marketing/sales, clinical and general management positions with General Electric Medical Systems, Spacelabs Medical (SLMD), Hewlett Packard Medical Group and Endosonics Corporation (ESON). Carroll has more than 40 years, experience in manufacturing, development, sales and marketing of medical devices. Carroll has a great amount of international experience in Europe and Israel from marketing to technology exchange. His experience is supported by a PhD in Allied Health Administration (Medical Ethics), an MBA in Management and a BA in Health Science (Sports Medicine).
As Executive Director of the Business Incubator at Brenau University, he saw it become a premier business incubator and is looking forward to continuing his work in education and all aspects of business development at CLT Consulting (his new company), in partnership with the University of Georgia, Emory University, Georgia Tech, University of North Georgia, Georgia State University, Northside Hospital, and Northeast Georgia Health System.
The patient receives medication via the Optimist Smart Metered Dose Inhaler
Optimist App downloads treatment schedule from cloud to the inhaler and collects patient feedback
Patient data is monitored and treatment regimen updates sent to the inhaler via the Optimist Physician's Portal
The R&D team has access to efficacy data to improve health
outcomes by yielding actionable insights
Optimist Screening is protected by patents in the U.S. and elsewhere. This web page is provided to satisfy the virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of the America Invents Act. The following list may not be all inclusive and other Optimist products listed here may be protected by one or more patents or patents pending. Optimist Inhaler LLC
Protected by U.S. Patent Numbers: 10,449,310B2 • D863,531 • D863,532 • D863,533 • D863,534 • D863,535
Additional patents may be pending in the U.S. and elsewhere.